HIGHLIGHTS
- who: Hec and collaborators from the , MB-231, MDA-MB-468, HeLa, MCF7, HCC1954, COLO205, U OS, Huh-7, HepG2, KG-1, PC3, BT474, MV4-11, have published the paper: Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1, in the Journal: (JOURNAL)
- what: This study explores the features and potential of the improved anticancer agent targeting Hec1, TAI-1, for preclinical development and clinical utility. This study shows a small_molecule with largely improved potency range enabling the preclinical development of a Hec1 targeted small_molecule. Even though the great leap . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.